Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors
about
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors
description
scientific article published on 07 December 2017
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2017
@uk
name
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@en
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@nl
type
label
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@en
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@nl
prefLabel
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@en
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@nl
P2093
P2860
P356
P1476
Identifying a Clinically Appli ...... kpoint Therapy in Solid Tumors
@en
P2093
Anil Betigeri
Dean C Pavlick
Douglas B Johnson
Edmund Lattime
Gyan Bhanot
Howard L Kaufman
Janice M Mehnert
Jeffrey S Ross
Jeffrey Sosman
P2860
P356
10.1200/PO.17.00146
P407
P577
2017-12-07T00:00:00Z